🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 17 of 39

  1. laronidase

    ALDURAZYME BioMarin Pharmaceutical Australia Pty Ltd

    FDA: approved · EMA: approved

    A16AB05

  2. latanoprost

    APO-LATANOPROST Alphapharm Pty Ltd

    OPHTHALMIC FDA: approved · EMA: approved · TGA: approved

    S01EE01

  3. lenacapavir

    SUNLENCA

    SUBCUTANEOUS FDA: approved · EMA: approved

    J05AX31

  4. letermovir

    PREVYMIS

    ORAL FDA: approved · EMA: approved · PMDA: approved

    J05

  5. linaclotide

    CONSTELLA

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    A06AX04

  6. lonafarnib

    ZOKINVY

    ORAL FDA: approved · EMA: approved

  7. lopinavir

    KALETRA

    ORAL FDA: approved · EMA: approved

    J05AR10

  8. lorlatinib

    LORVIQUA Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01ED05

  9. loxapine

    ADASUVE

    INHALATION FDA: approved · EMA: approved

    N05AH01

  10. lusutrombopag

    MULPLEO (PREVIOUSLY LUSUTROMBOPAG SHIONOGI)

    ORAL FDA: approved · EMA: approved · PMDA: approved

    B02BX

  11. macitentan

    OPSUMIT Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    C02KX54

  12. maraviroc

    CELSENTRI ViiV Healthcare Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AX09

  13. mavacamten

    CAMZYOS Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    C01EB

  14. mavorixafor

    XOLREMDI

    ORAL FDA: approved · EMA: approved

    L03AX24

  15. melphalan

    ALKERAN Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01AA03

  16. mepolizumab

    NUCALA GlaxoSmithKline

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    R03DX09

  17. mercaptopurine

    ALLMERCAP Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01BB02

  18. methotrexate

    ARX-METHOTREXATE Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AX03

  19. methoxy polyethylene glycol-epoetin beta

    MIRCERA Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved

    B03XA03

  20. methylnaltrexone bromide

    RELISTOR

    SUBCUTANEOUS FDA: approved · EMA: approved

    A06AH01

  21. metreleptin

    MYALEPTA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    A16AA

  22. midazolam

    PFIZER AUSTRALIA PTY LTD Pfizer Australia Pty Ltd

    NASAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N05CD08

  23. miglustat

    MIGLUSTAT DIPHARMA

    ORAL FDA: approved · EMA: approved

    A16AX06

  24. mirdametinib

    EZMEKLY

    ORAL FDA: approved · EMA: approved

    L01EE

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.